We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.89T
$205M 2.62%
1,689,396
+114,133
+7% +$12.5M
AMGN icon
2
Amgen
AMGN
$198B
$194M 2.48%
1,014,959
+38,384
+4% +$7.33M
BIIB icon
3
Biogen
BIIB
$29.7B
$155M 1.98%
654,495
+84,754
+15% +$26.7M
AAPL icon
4
Apple
AAPL
$4.76T
$150M 1.92%
3,032,456
+157,832
+5% +$6.69M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$68.2B
$143M 1.82%
347,271
-2,083
-0.6% -$858K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.25T
$142M 1.81%
2,385,940
+446,960
+23% +$25.2M
AMZN icon
7
Amazon
AMZN
$2.62T
$132M 1.69%
1,487,180
-211,380
-12% -$17.6M
GILD icon
8
Gilead Sciences
GILD
$164B
$131M 1.68%
1,999,264
+425,351
+27% +$28.3M
MRK icon
9
Merck
MRK
$316B
$130M 1.67%
1,632,454
+584,394
+56% +$43.7M
BABA icon
10
Alibaba
BABA
$280B
$125M 1.59%
682,348
+107,953
+19% +$18.2M
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$120B
$122M 1.56%
661,520
+26,135
+4% +$4.83M
CELG
12
DELISTED
Celgene Corp
CELG
$118M 1.51%
1,251,924
-859,400
-41% -$75.2M
META icon
13
Meta Platforms (Facebook)
META
$1.6T
$94.4M 1.21%
566,232
+103,908
+22% +$16.5M
BMY icon
14
Bristol-Myers Squibb
BMY
$124B
$94.1M 1.2%
1,973,239
+610,737
+45% +$30.4M
PG icon
15
Procter & Gamble
PG
$350B
$79M 1.01%
722,938
-55,733
-7% -$5.43M
DIS icon
16
Walt Disney
DIS
$168B
$78.6M 1.01%
671,243
+150,098
+29% +$16.8M
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$76.4M 0.98%
565,052
-60,845
-10% -$7.57M
V icon
18
Visa
V
$675B
$73M 0.93%
444,154
-34,734
-7% -$5.01M
XOM icon
19
ExxonMobil
XOM
$640B
$71.8M 0.92%
812,065
+128,593
+19% +$9.8M
ILMN icon
20
Illumina
ILMN
$29.2B
$71.6M 0.92%
236,861
-720
-0.3% -$210K
HD icon
21
Home Depot
HD
$332B
$63.3M 0.81%
309,946
+8,049
+3% +$1.48M
CSCO icon
22
Cisco
CSCO
$445B
$63.2M 0.81%
1,138,675
+169,610
+18% +$8.24M
JNJ icon
23
Johnson & Johnson
JNJ
$613B
$61M 0.78%
398,620
+21,096
+6% +$2.83M
ADBE icon
24
Adobe
ADBE
$88B
$53M 0.68%
198,686
+52,101
+36% +$13.1M
VZ icon
25
Verizon
VZ
$186B
$52M 0.67%
807,678
-7,887
-1% -$447K
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.